Citation Impact
Citing Papers
Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
2018
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Targeted Radiotherapy of Osteosarcoma Using153Sm-Edtmp: A new promising approach
1996
Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y
2009
Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids
2004
EGFR Antagonists in Cancer Treatment
2008 Standout
Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes
2007
Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping
2006 StandoutNobel
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
2007
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
2010
A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels–Alder Click Chemistry
2013
Taking advantage of luminescent lanthanide ions
2005 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Antibody-targeted radiation cancer therapy
2004
Tumour targeting with radiometals for diagnosis and therapy
2013
An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate‐specific membrane antigen small molecule derivatives
2006
Cancer Statistics, 2006
2006 Standout
Development of an in vitro model for assessing the in vivo stability of lanthanide chelates
2001
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization
2007
Liposome: classification, preparation, and applications
2013 Standout
The use of radioimmunoconjugates in stem cell transplantation
2002
PET Imaging of Soluble Yttrium-86-Labeled Carbon Nanotubes in Mice
2007
Polymer conjugates as anticancer nanomedicines
2006 Standout
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Radioimmunotherapy of human tumours
2015
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody
2011
The role of coordination chemistry in the development of target-specific radiopharmaceuticals
2004
The influence of Bz-DOTA and CHX-A″-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for 114mIn-mediated targeting therapy
2009
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Microenvironmental regulation of metastasis
2008 Standout
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
2010
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Nanoparticle-based targeted drug delivery
2009 Standout
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands
2010
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Review of clinical radioimmunotherapy
2006
Tumor Angiogenesis
2008 Standout
Renal clearance of quantum dots
2007 StandoutNobel
Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies
2005
High-affinity Near-infrared Fluorescent Small-molecule Contrast Agents for In Vivo Imaging of Prostate-specific Membrane Antigen
2005
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
2013
Synthesis and in Vitro Testing of J591 Antibody−Dendrimer Conjugates for Targeted Prostate Cancer Therapy
2004
High-Activity Samarium-153-EDTMP Therapy in Unresectable Osteosarcoma
1999
A highly effective bifunctional ligand for radioimmunotherapy applications
2011
Relationship between Size and Function of Natural Substance Particles
2011
Triboelectric Nanogenerator: A Foundation of the Energy for the New Era
2018 Standout
Efficient Bifunctional Decadentate Ligand 3p-C-DEPA for Targeted α-Radioimmunotherapy Applications
2011
Unconventional nuclides for radiopharmaceuticals.
2010
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Evolutionary trend analysis of nanogenerator research based on a novel perspective of phased bibliographic coupling
2017
Unconventional Nuclides for Radiopharmaceuticals
2010
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
2004
Bifunctional chelates for metal nuclides.
2008
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
2003
Novel Bimodal Bifunctional Ligands for Radioimmunotherapy and Targeted MRI
2008
Acute myeloid leukaemia
2016
Radiometals for Combined Imaging and Therapy
2012
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Works of Jim Simón being referenced
Design and synthesis of 225Ac radioimmunopharmaceuticals
2002
Comparison of Pretargeted and Conventional CC49 Radioimmunotherapy Using 149Pm, 166Ho, and 177Lu
2011
Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.
1990
Tumor Therapy with Targeted Atomic Nanogenerators
2001 Science